newsfilter
← Latest News
FDA Approved Drugs·

Approval of RYBREVANT FASPRO, BLA #761433

Approval Date: 11/05/2026 Drug Name: RYBREVANT FASPRO, BLA #761433 Submission: SUPPL-2 Active Ingredients: AMIVANTAMAB AND HYALURONIDASE-LPUJ Company: JANSSEN BIOTECH Submission Status: Approval Application Number: 761433

Company
JANSSEN BIOTECH
Keywords
AMIVANTAMAB AND HYALURONIDASE-LPUJ